Sugitani, Ikuko
Ueda, Shigeto
Sakurai, Takashi
Shigekawa, Takashi
Hirokawa, Eiko
Shimada, Hiroko
Takeuchi, Hideki
Matsuura, Kazuo
Misumi, Misono
Fujiuchi, Nobuko
Takahashi, Takao
Hasebe, Takahiro
Osaki, Akihiko
Saeki, Toshiaki
Clinical trials referenced in this document:
Documents that mention this clinical trial
Neoadjuvant chemotherapy with trastuzumab, docetaxel, and carboplatin administered every 3 weeks for Japanese women with HER2-positive primary breast cancer: efficacy and safety
https://doi.org/10.1007/s10147-017-1136-8
Article History
Received: 13 March 2017
Accepted: 7 May 2017
First Online: 25 May 2017
Compliance with ethical standards
:
: Toshiaki Saeki received lecture fees from Chugai Pharmaceutical Co., Ltd. The other authors declare that they had no conflict of interest.